Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FXJMY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,145
Award facts
- Contract value 100% obligated
- $25,144.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,144.81 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on June 16, 2025, with completion scheduled for June 17, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, making this procurement part of the Defense Logistics Agency's critical pharmaceutical supply chain supporting military healthcare programs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a potential value of $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's consistent receipt of competitively awarded delivery orders across multiple therapeutic domains demonstrates its established capability to meet federal medical procurement requirements and support ongoing military medical operations.
Quick answers
Who was awarded contract SPE2DB25FXJMY?
SPE2DB25FXJMY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 16, 2025.
How much is contract SPE2DB25FXJMY worth?
The government has obligated $25,145 on SPE2DB25FXJMY.
Is contract SPE2DB25FXJMY an order under another contract?
Yes. SPE2DB25FXJMY is a delivery order under SPE2DB25D3006, an indefinite delivery contract.
Was contract SPE2DB25FXJMY competed?
The extent of competition for SPE2DB25FXJMY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award